Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

    NEXT STORY
    My Other Life with Peter Bowman
    PREV STORY
    Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Paratek Pharmaceuticals Generates Net Revenues of $3.9 Million in the Third Quarter of 2019

    author_avatar
    NASDAQ Market News

    Novartis announces EU approval of Mayzent® (siponimod) for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease

    author_avatar
    NASDAQ Market News

    Cytokinetics Announces Presentation of Additional Analyses From FORTITUDE-ALS at the 18th Annual NEALS Meeting

    author_avatar
    NASDAQ Market News